Multiple Sclerosis

The AJMC® Multiple Sclerosis compendium is a comprehensive resource for clinical news and expert insights for the disabling disease that impacts the brain and spinal cord.

Latest News

Myelin sheath damage in MS concept | image credit: Artur - stock.adobe.com
Aerobic Exercise Could Benefit MS Management, Further Research Needed

June 7th 2024

A small cohort demonstrated the potential benefits aerobic exercise regimens hold for managing fatigue symptoms in multiple sclerosis (MS), but more studies are needed.

Eye imaging | Image credit: Richman Photo - stock.adobe.com
Retinal Vasculature Pathology Linked With MS Disease Burden

May 31st 2024

Cannabis Leaves and Stethoscope | image credit: New Africa - stock.adobe.com
Cannabis Treatment Showcases Promising Benefits for Managing Adverse Symptoms of MS

May 30th 2024

Man Wrestling With Sleeplessness | image credit: mtrlin - stock.adobe.com
Sleep Quality in MS Impacted by Comorbidities, Study Finds

May 16th 2024

RRMS AI-Concept | image credit: Evadne - stock.adobe.com
Serum Neurofilament Light Changes Not Always Apparent in Active RRMS, Study Finds

May 8th 2024

Continuing Medical Education
June 8th 2024

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

June 27, 2024 | 1:00 PM & 7:00 PM ET
June 8th 2024

Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

1.0 Credit / Neurology
June 8th 2024

Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances

2.0 Credits / Neurology
June 8th 2024

New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist

1.0 Credit / Neurology
June 8th 2024

Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden

1.5 Credits / Neurology
June 8th 2024

Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care

1.5 Credits / Neurology
June 8th 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
June 8th 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

More News

John Corboy, MD, University of Colorado Denver
October 30th 2020

Dr John Corboy on Probing Patient Quality of Life Off Medication for MS

Quality of life for patients with multiple sclerosis (MS) could be better when they are off medication because they will not have adverse effects related to those medications, said John Corboy, MD, professor of neurology, University of Colorado Denver, School of Medicine.
Cell division
October 24th 2020

MS Research Examines PPD, Ozanimod in Pregnancy

AJMC Staff
Two abstracts presented at a recent multiple sclerosis meeting examined depression in pregnancy and pregnancy outcomes in ozanimod trials.
Infant
October 24th 2020

Pregnancy Can Delay MS Onset by 3 Years, Study Says

Allison Inserro
The researchers noted that although it is known that pregnancy is linked to reduced MS activity, the effect of pregnancy before MS diagnosis is unclear.
Study Findings Highlight Differences in MS Characteristics Between Sex, Disease Course
October 15th 2020

Study Findings Highlight Differences in MS Characteristics Between Sex, Disease Course

Jaime Rosenberg
Differences in clinical and demographic characteristics between men and women with multiple sclerosis (MS) are more prevalent regarding disease course than they are when stratifying by sex.
John Corboy, MD, Rocky Mountain MS Center
October 13th 2020

Dr John Corboy Forecasts Promising Developments in Multiple Sclerosis

Rebooting the immune system is an exciting approach, noted John Corboy, MD, professor of neurology, University of Colorado Denver, School of Medicine, and co-director of the Rocky Mountain MS Center at Anschutz Medical Campus.
John Corboy, MD, Rocky Mountain MS Center
October 9th 2020

Dr John Corboy: Why Disease-Modifying Therapy Efficacy Varies With Age

Older individuals need medications that focus on effects inside the nervous system, explained John Corboy, MD, of University of Colorado Denver, School of Medicine, and Rocky Mountain MS Center at Anschutz Medical Campus.
patient and doctor
October 7th 2020

Studies Confirm Long-term Safety, Efficacy of Ozanimod in Relapsing Forms of MS

Laura Joszt, MA
Research on the long-term use of ozanimod in relapsing forms of multiple sclerosis (MS) has shown the treatment is effective with no new safety concerns.
Levels of MS Biomarker Rise When DMTs Stop in Pregnancy, Study Notes
October 3rd 2020

Levels of MS Biomarker Rise When DMTs Stop in Pregnancy, Study Notes

AJMC Staff
A recent study explored whether interrupting disease-modifying therapies (DMTs) because of pregnancy leads to increased levels of a specific biomarker of neuroaxonal injury seen in MS.
Dr Burcu Zeydan Discusses Factors in Managing Older Patients With MS
September 29th 2020

Dr Burcu Zeydan Discusses Factors in Managing Older Patients With MS

Tailoring treatment to individual patients is the ultimate goal in the complex decision-making process of managing progressive multiple sclerosis (MS), noted Burcu Zeydan, MD, assistant professor of neurology, assistant professor of radiology, Mayo Clinic.
Ocrelizumab, Rituximab Linked With More Severe COVID-19 in Multiple Sclerosis
September 25th 2020

Ocrelizumab, Rituximab Linked With More Severe COVID-19 in Multiple Sclerosis

Allison Inserro
The results were shared as part of the MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting, which is concluding Saturday with a special session about coronavirus disease 2019 (COVID-19).
Picture of open office
September 24th 2020

People With MS Face Higher Rates of Harassment, Criticism at Work Than Healthy Employees

Skylar Jeremias
Patients with multiple sclerosis (MS) reported higher rates of harassment and criticism in the workplace than their healthy counterparts, even after informing employers and coworkers about their diagnosis.
Dr Burcu Zeydan Discusses How, Why Postrelapse Recovery Potential Declines With Older Age in MS
September 23rd 2020

Dr Burcu Zeydan Discusses How, Why Postrelapse Recovery Potential Declines With Older Age in MS

Relapse at an older age can significantly contribute to a worsening of multiple sclerosis (MS), explained Burcu Zeyda, MD, assistant professor of neurology, assistant professor of radiology, at Mayo Clinic.
Patricia K. Coyle, MD, screenshot
September 18th 2020

Dr Patricia Coyle Underscores the Importance of Diagnosing and Treating MS Early

Emerging data is showing that treatment within 6 months of presentation of multiple sclerosis (MS) is ideal, explained Patricia K. Coyle, MD, of Stony Brook University Neurosciences Institute.
Combined Training Program Improves Balance, Static Strength in Patients With MS
September 11th 2020

Combined Training Program Improves Balance, Static Strength in Patients With MS

Jaime Rosenberg
Results of a combined training program in 17 patients with multiple sclerosis indicate patients reap benefits from daily activities like walking or sitting-to-standing, and show the program reduces the dual-task cost of performing cognitive tasks while walking.
Case Study Highlights Possible Relationship Between MS, IBD
September 5th 2020

Case Study Highlights Possible Relationship Between MS, IBD

Jaime Rosenberg
The authors suggest that recognizing the possible link may help identify patients at greater risk, although they do caution that larger studies are needed.
Hands
September 4th 2020

Engineered Gloves Show Promise at Measuring MS Limb Disability

AJMC Staff
A small study says that gloves with sensors could measure impairments in hand function and may have advantages over standard methods.
Patients, Physicians Largely Agree on Presence of MS Relapse, Analysis Finds
August 29th 2020

Patients, Physicians Largely Agree on Presence of MS Relapse, Analysis Finds

Jaime Rosenberg
Patients were more likely to report more relapses of multiple sclerosis than physicians.
European Study Finds Patients With MS Adhere Better to Oral Therapies
August 23rd 2020

European Study Finds Patients With MS Adhere Better to Oral Therapies

Allison Inserro
Adherence to multiple sclerosis (MS) therapy is linked with improved clinical outcomes, better quality of life, lower health care costs, and other benefits.
FDA Approves Ofatumumab for Relapsing MS
August 21st 2020

FDA Approves Ofatumumab for Relapsing MS

AJMC Staff
For multiple sclerosis, the therapy will be sold as Kesimpta by Novartis; it is administered by patients once a month through the Sensoready autoinjector pen.
THC, CBD Combo Eases MS Symptoms, Extends Cutaneous Silent Period
August 20th 2020

THC, CBD Combo Eases MS Symptoms, Extends Cutaneous Silent Period

Jaime Rosenberg
A combination of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) relieved certain neurophysiological symptoms affecting patients with secondary progressive multiple sclerosis (MS).
Question mark
August 15th 2020

Which Factors of MS Treatment Satisfaction Have Strongest Effect on HRQOL?

Allison Inserro
Certain aspects of satisfaction with multiple sclerosis (MS) treatment can impact health-related quality of life (HRQOL).
Brain picture
August 14th 2020

Measuring Gray Matter in the Brain to Predict MS Decline

Allison Inserro
The thalamus is among the first brain areas to atrophy in multiple sclerosis (MS); this study wanted to know if measuring this loss can predict future disability.
Do Stressful Life Events Trigger Later MS Diagnosis?
August 8th 2020

Do Stressful Life Events Trigger Later MS Diagnosis?

Allison Inserro
Study Describes Ozanimod’s Mechanism of Action in Relapsing MS
August 6th 2020

Study Describes Ozanimod’s Mechanism of Action in Relapsing MS

Jared Kaltwasser
A new analysis offers insights into how ozanimod works in patients with relapsing multiple sclerosis, as well as the impact of higher dosage.
New Study Elucidates Early Visual Symptoms of Pediatric Onset MS
July 31st 2020

New Study Elucidates Early Visual Symptoms of Pediatric Onset MS

Jared Kaltwasser
A new study helps make clear what’s happening in the visual systems of patients with pediatric onset multiple sclerosis.
Pregnancy Outcomes Mirror General Population in Women With MS Who Took Alemtuzumab
July 26th 2020

Pregnancy Outcomes Mirror General Population in Women With MS Who Took Alemtuzumab

Jared Kaltwasser
Alemtuzumab did not appear to negatively impact pregnancy outcomes in women who took the therapy for relapsing-remitting multiple sclerosis prior to becoming pregnant.
One in 5 Patients With MS Don't Adhere to Oral DMDs
July 24th 2020

One in 5 Patients With MS Don't Adhere to Oral DMDs

Jaime Rosenberg
The researchers noted that these results can help inform therapeutic decision making and identify opportunities to address barriers to disease-modifying drug (DMD) adherence, which not only improves clinical outcomes but also reaps benefits when it comes to health care costs.
Social Media May Benefit Patients With MS-Associated Depression
July 19th 2020

Social Media May Benefit Patients With MS-Associated Depression

Skylar Jeremias
By delivering helpful information and fostering online communities, social media may provide rehabilitation and psychological benefits for patients with multiple sclerosis (MS) who have depression, according to the results of a recent Iranian study.
In MS, Leg Function Declines More Rapidly Than Hand Function, Study Finds
July 18th 2020

In MS, Leg Function Declines More Rapidly Than Hand Function, Study Finds

Jared Kaltwasser
A new study suggests patients with multiple sclerosis (MS) will see their ability to walk decline more rapidly than their hand function.
More Research Needed on Effects of MS in Women, Authors Say
July 17th 2020

More Research Needed on Effects of MS in Women, Authors Say

Mary Caffrey
The review article highlights the many ways that multiple sclerosis (MS) affects women over the lifespan, from pregnancy to childbirth to menopause and beyond—and how both research and clinical practice fall short in meeting their needs.
<12345678910
...
20>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo